Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,063

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties

Open access
Wager, Travis T., Hou, Xinjun, Verhoest, Patrick R., Villalobos, Anabella·2010·ACS Chemical Neuroscience

Abstract

The interplay among commonly used physicochemical properties in drug design was examined and utilized to create a prospective design tool focused on the alignment of key druglike attributes. Using a set of six physicochemical parameters ((a) lipophilicity, calculated partition coefficient (ClogP); (b) calculated distribution coefficient at pH = 7.4 (ClogD); (c) molecular weight (MW); (d) topological polar surface area (TPSA); (e) number of hydrogen bond donors (HBD); (f) most basic center (pK(a))), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compounds (N = 11 303). The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates. This analysis suggests that this algorithm could potentially be used to identify compounds with a higher probability of successfully testing hypotheses in the clinic. In addition, a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set. The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chemistry design space through a holistic assessment approach. Based on six physicochemical properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compounds with increased probability of success.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/cn100008c

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 21

  1. Abad-Zapatero C., 2007, Expert Opin. Drug Discovery, 2, 469, 10.1517/17460441.2.4.469 · DOI · Paper page
  2. Keserue G. M., 2009, Nat. Rev. Drug Discovery, 8, 203, 10.1038/nrd2796 · DOI · Paper page
  3. Kalgutkar A. S., 2008, Biotechnol.: Pharm. Aspects, 9, 27
  4. Kalgutkar A. S., 2005, Curr. Drug Metab., 6, 161, 10.2174/1389200054021799 · DOI · Paper page
  5. Kalgutkar A. S., 2005, Expert Opin. Drug Metab. Toxicol., 1, 91, 10.1517/17425255.1.1.91 · DOI · Paper page
  6. 10.1021/cn100007x · DOI · Paper page
  7. Ertl P., 2000, J. Med. Chem., 43, 3714, 10.1021/jm000942e · DOI · Paper page
  8. Feng B., 2008, Drug Metab. Dispos., 36, 268, 10.1124/dmd.107.017434 · DOI · Paper page
  9. Hosea N. A., 2009, J. Clin. Pharmacol., 49, 513, 10.1177/0091270009333209 · DOI · Paper page
  10. Gao H., 2008, Drug Metab. Dispos., 36, 2130, 10.1124/dmd.107.020131 · DOI
  11. Hughes J. D., 2008, Bioorg. Med. Chem. Lett., 18, 4872, 10.1016/j.bmcl.2008.07.071 · DOI · Paper page
  12. Lipinski C. A., 2004, Drug Discovery Today: Technol., 1, 337, 10.1016/j.ddtec.2004.11.007 · DOI · Paper page
  13. Waterhouse Rikki N., 2003, Mol. Imaging Biol., 5, 376, 10.1016/j.mibio.2003.09.014 · DOI · Paper page
  14. E. C. Harrington J., 1965, Ind. Qual. Control, 21, 494
  15. Le Bailly de Tilleghem C., 2005, J. Chem. Inf. Model., 45, 758, 10.1021/ci049787t · doi:10.1021/ci049787t
  16. Mandal A., 2007, J. Chem. Inf. Model., 47, 981, 10.1021/ci600556v · doi:10.1021/ci600556v
  17. Gehlhaar D. K., 1995, Chem. Biol., 2, 317, 10.1016/1074-5521(95)90050-0 · DOI · Paper page
  18. Deacon M., 2007, J. Pharmacol. Toxicol. Methods, 55, 238, 10.1016/j.vascn.2006.09.003 · doi:10.1016/j.vascn.2006.09.003
  19. Lowe C. W., 1967, Trans. Inst. Chem. Eng., 45, T3
  20. Walum E., 2005, Toxicol. Appl. Pharmacol., 207, S393, 10.1016/j.taap.2005.01.056 · DOI
  21. Fermini B., 2003, Nat. Rev. Drug Discovery, 2, 439, 10.1038/nrd1108 · DOI · Paper page

Cited by

See all 1,063

Metadata

Authors
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A.
Venue
ACS Chemical Neuroscience
Published
2010-03-25
Volume
1
Issue
6
Pages
435-449
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2016575780
Cited by
1,063
References
2
FWCI
38.21
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.